Home > Healthcare > Medical Devices > Therapeutic Devices > stoma care market
Get a free sample of Stoma Care Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Stoma Care Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Increasing prevalence of inflammatory bowel diseases (IBD) is one of the significant factor that is anticipated to drive the market growth. Inflammatory bowel diseases refer to a group of chronic inflammatory conditions that primarily affect the gastrointestinal tract. These conditions can lead to severe symptoms and complications, often necessitating surgical interventions, including ostomy surgery. The global incidence of IBD has been steadily increasing over the years. For instance, according to the European Federation of Crohn's and Ulcerative Colitis Associations data, in 2022, around 10 million individuals globally were estimated to suffer from inflammatory bowel diseases. As more individuals are diagnosed with conditions such as Crohn's disease and ulcerative colitis, the demand for ostomy surgeries to manage these diseases is expected to increase significantly.
Ostomy surgery can provide relief from debilitating symptoms and improve patients' quality of life. As the number of individuals undergoing ostomy surgery increases, the demand for stoma care devices and related products. Ostomy surgery often results in a permanent or long-term stoma. Individuals who undergo ostomy surgery require ongoing stoma care and use stoma care devices, such as ostomy bags and skin barriers, to effectively manage their condition. This creates a continuous need for stoma care products throughout a patient's life. The increasing prevalence of IBD has driven research and innovation in stoma care technology. Manufacturers are developing advanced stoma care devices with features such as improved adhesives, odour control, and ergonomic designs. These innovations contribute to better patient outcomes and encourage market progress.
The colostomy surgery segment accounted for USD 1.5 billion in 2022 and will continue the growth through 2032, attributable to the rising geriatric population and increases in the risk of colorectal cancer cases.
Stoma care industry was valued at around USD 3.2 billion in 2022 and is projected to reach over USD 5.2 billion by 2032, owing to increasing prevalence of chronic diseases.
North America stoma care market was valued at over USD 646 million in 2022 and will showcase strong growth over 2023-2032, ascribed to the increase in the number of patients suffering from IBD, and expanding elderly population.
Coloplast A/S, B Braun Melsungen AG, Hollister Inc., ConvaTec Group Plc., Salts Healthcare, Welland Medical Limited, Alcare Co., LTD, Nu-Hope Labs, Smith & Nephew, Flexicare Ltd., Torbot Group Inc., Cymed Micro Skin, 3M Company among others.